Cytoreduction Surgical Procedures
"Cytoreduction Surgical Procedures" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Operative procedures carried out to reduce a mass of tissue, for example, to reduce the total amount of tissue composing a tumor.
| Descriptor ID |
D065426
|
| MeSH Number(s) |
E04.166
|
| Concept/Terms |
Cytoreduction Surgical Procedures- Cytoreduction Surgical Procedures
- Cytoreduction Surgical Procedure
- Procedure, Cytoreduction Surgical
- Surgical Procedure, Cytoreduction
- Debulking Surgical Procedures
- Debulking Surgical Procedure
- Procedure, Debulking Surgical
- Surgical Procedure, Debulking
- Cytoreductive Surgery
- Cytoreductive Surgeries
- Surgery, Cytoreductive
- Cytoreductive Surgical Procedures
- Cytoreductive Surgical Procedure
- Procedure, Cytoreductive Surgical
- Surgical Procedure, Cytoreductive
- Surgical Procedures, Cytoreductive
|
Below are MeSH descriptors whose meaning is more general than "Cytoreduction Surgical Procedures".
Below are MeSH descriptors whose meaning is more specific than "Cytoreduction Surgical Procedures".
This graph shows the total number of publications written about "Cytoreduction Surgical Procedures" by people in this website by year, and whether "Cytoreduction Surgical Procedures" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 1 | 1 |
| 2017 | 14 | 7 | 21 |
| 2018 | 17 | 5 | 22 |
| 2019 | 4 | 7 | 11 |
To return to the timeline, click here.
Below are the most recent publications written about "Cytoreduction Surgical Procedures" by people in Profiles.
-
Maintaining surgical care delivery during the COVID-19 pandemic: A comparative cohort study at a tertiary gynecological cancer centre. Gynecol Oncol. 2021 03; 160(3):649-654.
-
Evidence-Based Strategies for the Treatment of Peritoneal Malignancies during Health Care Resource Restriction: The COVID-19 Pandemic. Curr Oncol. 2020 12 01; 28(1):40-51.
-
Survival outcomes after delayed cytoreduction surgery following neoadjuvant chemotherapy in advanced epithelial ovarian cancer. Int J Gynecol Cancer. 2020 12; 30(12):1935-1942.
-
[Fever, loss of vision and acute promyelocytic leukemia at the pandemic ward]. Ugeskr Laeger. 2020 07 13; 182(29).
-
[Guidelines for surgical management of gynaecological cancer during pandemic COVID-19 period - FRANCOGYN group for the CNGOF]. Gynecol Obstet Fertil Senol. 2020 05; 48(5):444-447.
-
Survival Outcomes Among Patients With Gastric Adenocarcinoma Who Received Hyperthermic Intraperitoneal Chemotherapy With Cytoreductive Surgery. JAMA Surg. 2019 08 01; 154(8):780-782.
-
Systematic review of published literature on oxaliplatin and mitomycin C as chemotherapeutic agents for hyperthermic intraperitoneal chemotherapy in patients with peritoneal metastases from colorectal cancer. Crit Rev Oncol Hematol. 2019 Oct; 142:119-129.
-
Complication rates, failure to rescue and in-hospital mortality after cytoreductive nephrectomy in the older patients. J Geriatr Oncol. 2020 05; 11(4):718-723.
-
Financial toxicity risk among adult patients undergoing cancer surgery in the United States: An analysis of the National Inpatient Sample. J Surg Oncol. 2019 Sep; 120(3):397-406.
-
Prognostic factors value of germline and somatic brca in patients undergoing surgery for recurrent ovarian cancer with liver metastases. Eur J Surg Oncol. 2019 Nov; 45(11):2096-2102.